Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Phase 3 Study of CAOMECS for Total Limbal Stem Cell Deficiency
2011-000598-30Phase 3Terminated
- Sponsor
- CellSeed France
- Start
- Sep 2011
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, single-arm trial of cultivated oral mucosal epithelial sheet in limbal stem cell deficiency (LSCD), sponsored by CellSeed France. Started Sep 2011; status: terminated.
02
Drugs
cultivated oral mucosal epithelial sheet
03
Conditions
limbal stem cell deficiency (LSCD)
Beyond the preview
Go deeper on 2011-000598-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000598-30.